Literature DB >> 11427666

Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis.

K J Stas, J Vanwalleghem, B De Moor, H Keuleers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11427666     DOI： 10.1093/ndt/16.7.1521-a

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  9 in total

Review 1.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

Review 2.  Citrate chemistry and biology for biomaterials design.

Authors:  Chuying Ma; Ethan Gerhard; Di Lu; Jian Yang
Journal:  Biomaterials       Date:  2018-05-04       Impact factor: 12.479

3.  Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing.

Authors:  C Lersch; W Kotowa; S Fung; D Janssen
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-04       Impact factor: 4.553

Review 4.  Vascular access in elderly patients with end-stage renal disease.

Authors:  Nikolaos Bessias; Kosmas I Paraskevas; Effie Tziviskou; Vassilios Andrikopoulos
Journal:  Int Urol Nephrol       Date:  2008-09-16       Impact factor: 2.370

5.  Minimizing hemodialysis catheter dysfunction: an ounce of prevention.

Authors:  Timmy Lee; Charmaine Lok; Miguel Vazquez; Louise Moist; Ivan Maya; Michele Mokrzycki
Journal:  Int J Nephrol       Date:  2012-02-19

6.  Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449].

Authors:  Brenda R Hemmelgarn; Louise Moist; Rachel M Pilkey; Charmaine Lok; Marc Dorval; Paul Y W Tam; Murray J Berall; Martine LeBlanc; Edwin B Toffelmire; Braden J Manns; Nairne Scott-Douglas
Journal:  BMC Nephrol       Date:  2006-04-11       Impact factor: 2.388

7.  Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.

Authors:  Rémi Bruyère; Agnès Soudry-Faure; Gilles Capellier; Christine Binquet; Abdelouaid Nadji; Stephane Torner; Gilles Blasco; Maria Yannaraki; Saber Davide Barbar; Jean-Pierre Quenot
Journal:  Trials       Date:  2014-11-19       Impact factor: 2.279

Review 8.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30

9.  Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).

Authors:  Janusz Steczko; Stephen R Ash; David E Nivens; Lloyd Brewer; Roland K Winger
Journal:  Nephrol Dial Transplant       Date:  2009-01-30       Impact factor: 5.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.